AUG 30,2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Molecular Diagnostics Market.
This report, from Stratview Research, studies the Molecular Diagnostics Market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Molecular Diagnostics Market: Highlights
Why clinical molecular diagnostics is gaining clinical importance? Compared with conventional culture-based techniques, molecular diagnostic approaches provide substantially more rapid and specific information on organism identification and on the presence of resistance mechanisms. Such method enhances antimicrobial stewardship and decreases ‘time to appropriate antibiotics’, one of the most important factors in improving the prognosis of patients with life-threatening infections and improves DALY.
Molecular diagnostics of infectious diseases especially nucleic-acid-based processes, are the fastest growing field in clinical laboratory diagnostics. It involves stepwise replacing or complementing culture-based, biochemical, and immunological assays in microbiology laboratories. The first-generation nucleic acid assays were mono-parametric such as conventional tests, determining only a single parameter. With the introduction of advanced technologies such as microarrays, multiplex nucleic acid amplification techniques, or mass spectrometry, have actually reduced contamination risk while increasing the turnaround time (TAT) of results.
The Molecular Diagnostics Market is segmented into the following categories:
By Indication
- Infectious Disease, Oncology, Genetic Testing, Others.
By Technology
- PCR, DNA Sequencing, NGS, Other Testing.
By Product & Service
- Reagent, Software and After sales Services.
By Testing Facility
- Hospital Laboratories, Diagnostic Clinics, Mobile Clinics/Physician’s Office.
By Region
- North America (Country Analysis: the USA, Canada)
- Western Europe (Country Analysis: Germany, France, the UK)
- Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
- Latin America (Country Analysis: Brazil, Argentina, Mexico, and Others)
- Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others)
Key Players:
- Danaher Corporation (US),
- Becton, Dickinson and Company (US),
- Abbott Laboratories (US),
- Becton,
- Dickinson and Company
- Biomérieux SA.
Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
The Molecular Diagnostics Market analysis report discusses the following heads in great detail:
- Market structure: Overview, industry life cycle analysis, supply chain analysis
- COVID-19 Impact Assessment
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
- Market trend and forecast analysis
- Market segment trend and forecast
- Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
- Attractive market segments and associated growth opportunities
- Emerging trends
- Strategic growth opportunities for the existing and new players
- Key success factors